Cynosure Group’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.32M Hold
20,645
0.2% 33
2026
Q1
$1.57M Sell
20,645
-4,344,817
-100% -$343M 0.2% 45
2025
Q4
$46.4M Buy
4,365,462
+4,344,817
+21,045% +$339M 4.72% 5
2025
Q3
$1.55M Hold
20,645
0.17% 52
2025
Q2
$1.53M Hold
20,645
0.17% 60
2025
Q1
$1.67M Sell
20,645
-11,727
-36% -$1.01M 0.23% 51
2024
Q4
$2.53M Sell
32,372
-160
-0.5% -$13.6K 0.38% 35
2024
Q3
$3.05M Buy
32,532
+11,890
+58% +$998K 0.45% 35
2024
Q2
$1.61M Sell
20,642
-11
-0.1% -$897 0.26% 53
2024
Q1
$1.88M Sell
20,653
-113
-0.5% -$9.4K 0.34% 41
2023
Q4
$1.61M Buy
20,766
+17
+0.1% +$1.19K 0.29% 73
2023
Q3
$1.41M Sell
20,749
-3,958
-16% -$288K 0.43% 54
2023
Q2
$2.01M Buy
24,707
+15,819
+178% +$1.26M 0.6% 42
2023
Q1
$729K Buy
+8,888
New +$635K 1.1% 23

Other funds holding GEHC

Cynosure Group's GEHC Position: Q2 2026 in Review

Cynosure Group held its GE HealthCare (GEHC) position steady in Q2 2026 at 20,645 shares worth $1.32M. The position accounts for 0.2% of the portfolio, ranked #33.

Cynosure Group first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $46.4M in Q4 2025. 1,227 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Cynosure Group held 20,645 shares of GE HealthCare worth $1.32M as of Q2 2026.
  • Cynosure Group left its GE HealthCare share count unchanged in Q2 2026.
  • GE HealthCare made up 0.2% of Cynosure Group's portfolio in Q2 2026, its #33 holding.
  • Cynosure Group first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Cynosure Group's GE HealthCare position peaked at $46.4M in Q4 2025.
  • 1,227 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Cynosure Group's 13F filing for Q2 2026, filed 5 Aug 2026.